Multiple-integrations of HPV16 genome and altered transcription of viral oncogenes and cellular genes are associated with the development of cervical cancer

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Lu, Xulian ^a,b   Lin, Qiaoai ^a   Lin, Mao ^a,c   Duan, Ping ^a   Ye, Lulu ^a   Chen, Jun ^a   Chen, Xiangmin ^a   Zhang, Lifang ^a   Xue, Xiangyang ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

^b ZHUJI PEOPLE S HOSPITAL OF ZHEJIANG PROVINCE   (China)

^c MEDICAL COLLEGE OF JINAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN E7; ONCOPROTEIN; VIRUS PROTEIN;

AMPLIFICATION OF PAPILLOMAVIRUS ONCOGENE TRANSCRIPTS; ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; GENE EXPRESSION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; NONHUMAN; PAPILLOMAVIRUS INFECTION; PERSISTENT VIRUS INFECTION; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA; UTERINE CERVIX CARCINOMA IN SITU; VIRUS CARCINOGENESIS; VIRUS DNA CELL DNA INTERACTION; VIRUS GENOME; VIRUS ONCOGENE; BIOSYNTHESIS; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; UTERINE CERVIX TUMOR; VIROLOGY;

FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE EXPRESSION REGULATION, VIRAL; GENOME, VIRAL; HUMAN PAPILLOMAVIRUS 16; HUMANS; ONCOGENE PROTEINS; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VIRAL PROTEINS;

EID: 84903764621     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0097588     Document Type: Article

References (61)

1. zur Hausen H (1991) Human papillomaviruses in the pathogenesis of anogenital cancer. Virology 184: 9-13.
2. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, et al. (2003) Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 348: 518-527. (Pubitemid 36159887)
3. Kelley ML, Keiger KE, Lee CJ, Huibregtse JM (2005) The global transcriptional effects of the human papillomavirus E6 protein in cervical carcinoma cell lines are mediated by the E6AP ubiquitin ligase. J Virol 79: 3737-3747. (Pubitemid 40327961)
4. Scheffner M, Werness BA, Huibregtse JM, Levine AJ, Howley PM (1990) The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 63: 1129-1136. (Pubitemid 120035062)
5. Wang J, Sampath A, Raychaudhuri P, Bagchi S (2001) Both Rb and E7 are regulated by the ubiquitin proteasome pathway in HPV-containing cervical tumor cells. Oncogene 20: 4740-4749. (Pubitemid 32762445)
6. Ying H, Xiao ZX (2006) Targeting retinoblastoma protein for degradation by proteasomes. Cell Cycle 5: 506-508. (Pubitemid 43340528)
7. Incassati A, Patel D, McCance DJ (2006) Induction of tetraploidy through loss of p53 and upregulation of Plk1 by human papillomavirus type-16 E6. Oncogene 25: 2444-2451.
8. Romanczuk H, Thierry F, Howley PM (1990) Mutational analysis of cis elements involved in E2 modulation of human papillomavirus type 16 P97 and type 18 P105 promoters. J Virol 64: 2849-2859. (Pubitemid 20171275)
9. Smotkin D, Wettstein FO (1986) Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein. Proc Natl Acad Sci U S A 83: 4680-4684. (Pubitemid 16075465)
10. Hummel M, Hudson JB, Laimins LA (1992) Differentiation-induced and constitutive transcription of human papillomavirus type 31b in cell lines containing viral episomes. J Virol 66: 6070-6080.
11. Ozbun MA, Meyers C (1997) Characterization of late gene transcripts expressed during vegetative replication of human papillomavirus type 31b. J Virol 71: 5161-5172. (Pubitemid 27258188)
12. Schneider-Gadicke A, Schwarz E (1986) Different human cervical carcinoma cell lines show similar transcription patterns of human papillomavirus type 18 early genes. EMBO J 5: 2285-2292.
13. Thierry F, Heard JM, Dartmann K, Yaniv M (1987) Characterization of a transcriptional promoter of human papillomavirus 18 and modulation of its expression by simian virus 40 and adenovirus early antigens. J Virol 61: 134-142. (Pubitemid 17212454)
14. Steger G, Corbach S (1997) Dose-dependent regulation of the early promoter of human papillomavirus type 18 by the viral E2 protein. J Virol 71: 50-58. (Pubitemid 26412264)
15. Galvan SC, Martinez-Salazar M, Galvan VM, Mendez R, Diaz-Contreras GT, et al. (2011) Analysis of CpG methylation sites and CGI among human papillomavirus DNA genomes. BMC Genomics 12: 580.
16. Cornelissen MT, Smits HL, Briet MA, van den Tweel JG, Struyk AP, et al. (1990) Uniformity of the splicing pattern of the E6/E7 transcripts in human papillomavirus type 16-transformed human fibroblasts, human cervical premalignant lesions and carcinomas. J Gen Virol 71 (Pt 5): 1243-1246. (Pubitemid 20174368)
17. Smotkin D, Prokoph H, Wettstein FO (1989) Oncogenic and nononcogenic human genital papillomaviruses generate the E7 mRNA by different mechanisms. J Virol 63: 1441-1447. (Pubitemid 19061390)
18. Schwartz S (2008) HPV-16 RNA processing. Front Biosci 13: 5880-5891.
19. Zheng ZM, Baker CC (2006) Papillomavirus genome structure, expression, and post-transcriptional regulation. Front Biosci 11: 2286-2302.
20. Wang X, Meyers C, Wang HK, Chow LT, Zheng ZM (2011) Construction of a full transcription map of human papillomavirus type 18 during productive viral infection. J Virol 85: 8080-8092.
21. Badaracco G, Venuti A, Sedati A, Marcante ML (2002) HPV16 and HPV18 in genital tumors: Significantly different levels of viral integration and correlation to tumor invasiveness. J Med Virol 67: 574-582. (Pubitemid 34747680)
22. Hopman AH, Smedts F, Dignef W, Ummelen M, Sonke G, et al. (2004) Transition of high-grade cervical intraepithelial neoplasia to micro-invasive carcinoma is characterized by integration of HPV 16/18 and numerical chromosome abnormalities. J Pathol 202: 23-33. (Pubitemid 38072842)
23. Ferber MJ, Thorland EC, Brink AA, Rapp AK, Phillips LA, et al. (2003) Preferential integration of human papillomavirus type 18 near the c-myc locus in cervical carcinoma. Oncogene 22: 7233-7242. (Pubitemid 37378556)
24. Peter M, Rosty C, Couturier J, Radvanyi F, Teshima H, et al. (2006) MYC activation associated with the integration of HPV DNA at the MYC locus in genital tumors. Oncogene 25: 5985-5993. (Pubitemid 44477292)
25. Reuter S, Bartelmann M, Vogt M, Geisen C, Napierski I, et al. (1998) APM-1, a novel human gene, identified by aberrant co-transcription with papillomavirus oncogenes in a cervical carcinoma cell line, encodes a BTB/POZ-zinc finger protein with growth inhibitory activity. EMBO J 17: 215-222. (Pubitemid 28041062)
26. Klaes R, Woerner SM, Ridder R, Wentzensen N, Duerst M, et al. (1999) Detection of high-risk cervical intraepithelial neoplasia and cervical cancer by amplification of transcripts derived from integrated papillomavirus oncogenes. Cancer Res 59: 6132-6136. (Pubitemid 30035633)
27. Nishimura A, Ono T, Ishimoto A, Dowhanick JJ, Frizzell MA, et al. (2000) Mechanisms of human papillomavirus E2-mediated repression of viral oncogene expression and cervical cancer cell growth inhibition. J Virol 74: 3752-3760. (Pubitemid 30180318)
28. Jeon S, Allen-Hoffmann BL, Lambert PF (1995) Integration of human papillomavirus type 16 into the human genome correlates with a selective growth advantage of cells. J Virol 69: 2989-2997.
29. Jeon S, Lambert PF (1995) Integration of human papillomavirus type 16 DNA into the human genome leads to increased stability of E6 and E7 mRNAs: implications for cervical carcinogenesis. Proc Natl Acad Sci U S A 92: 1654-1658.
30. von Knebel Doeberitz M, Bauknecht T, Bartsch D, zur Hausen H (1991) Influence of chromosomal integration on glucocorticoid-regulated transcription of growth-stimulating papillomavirus genes E6 and E7 in cervical carcinoma cells. Proc Natl Acad Sci U S A 88: 1411-1415. (Pubitemid 21916234)
31. Wentzensen N, Ridder R, Klaes R, Vinokurova S, Schaefer U, et al. (2002) Characterization of viral-cellular fusion transcripts in a large series of HPV16 and 18 positive anogenital lesions. Oncogene 21: 419-426. (Pubitemid 34123804)
32. Van Tine BA, Kappes JC, Banerjee NS, Knops J, Lai L, et al. (2004) Clonal selection for transcriptionally active viral oncogenes during progression to cancer. J Virol 78: 11172-11186. (Pubitemid 39299657)
33. Dictor M, Warenholt J (2011) Single-tube multiplex PCR using type-specific E6/E7 primers and capillary electrophoresis genotypes 21 human papilloma-viruses in neoplasia. Infect Agent Cancer 6: 1.
34. Frohman MA, Dush MK, Martin GR (1988) Rapid production of full-length cDNAs from rare transcripts: amplification using a single gene-specific oligonucleotide primer. Proc Natl Acad Sci U S A 85: 8998-9002. (Pubitemid 19001832)
35. Hsu EM, McNicol PJ, Guijon FB, Paraskevas M (1993) Quantification of HPV-16 E6-E7 transcription in cervical intraepithelial neoplasia by reverse transcriptase polymerase chain reaction. Int J Cancer 55: 397-401. (Pubitemid 23300587)
36. Ordonez RM, Espinosa AM, Sanchez-Gonzalez DJ, Armendariz-Borunda J, Berumen J (2004) Enhanced oncogenicity of Asian-American human papillomavirus 16 is associated with impaired E2 repression of E6/E7 oncogene transcription. J Gen Virol 85: 1433-1444. (Pubitemid 38811424)
37. Nam DK, Lee S, Zhou G, Cao X, Wang C, et al. (2002) Oligo(dT) primer generates a high frequency of truncated cDNAs through internal poly(A) priming during reverse transcription. Proc Natl Acad Sci U S A 99: 6152-6156. (Pubitemid 34493281)
38. Liu SS, Tsang PC, Chan KY, Cheung AN, Chan KK, et al. (2008) Distribution of six oncogenic types of human papillomavirus and type 16 integration analysis in Chinese women with cervical precancerous lesions and carcinomas. Tumour Biol 29: 105-113.
39. Arias-Pulido H, Peyton CL, Joste NE, Vargas H, Wheeler CM (2006) Human papillomavirus type 16 integration in cervical carcinoma in situ and in invasive cervical cancer. J Clin Microbiol 44: 1755-1762. (Pubitemid 43726265)
40. Xu B, Chotewutmontri S, Wolf S, Klos U, Schmitz M, et al. (2013) Multiplex Identification of Human Papillomavirus 16 DNA Integration Sites in Cervical Carcinomas. PLoS ONE 8: e66693.
41. Thorland EC, Myers SL, Gostout BS, Smith DI (2003) Common fragile sites are preferential targets for HPV16 integrations in cervical tumors. Oncogene 22: 1225-1237. (Pubitemid 36363386)
42. Ziegert C, Wentzensen N, Vinokurova S, Kisseljov F, Einenkel J, et al. (2003) A comprehensive analysis of HPV integration loci in anogenital lesions combining transcript and genome-based amplification techniques. Oncogene 22: 3977-3984. (Pubitemid 36819671)
43. Dall KL, Scarpini CG, Roberts I, Winder DM, Stanley MA, et al. (2008) Characterization of naturally occurring HPV16 integration sites isolated from cervical keratinocytes under noncompetitive conditions. Cancer Res 68: 8249-8259.
44. Kraus I, Driesch C, Vinokurova S, Hovig E, Schneider A, et al. (2008) The majority of viral-cellular fusion transcripts in cervical carcinomas cotranscribe cellular sequences of known or predicted genes. Cancer Res 68: 2514-2522. (Pubitemid 351521828)
45. Schmitz M, Driesch C, Jansen L, Runnebaum IB, Durst M (2012) Non-random integration of the HPV genome in cervical cancer. PLoS ONE 7: e39632.
46. Zheng ZM, Wang X (2011) Regulation of cellular miRNA expression by human papillomaviruses. Biochim Biophys Acta 1809: 668-677.
47. Guzman VB, Yambartsev A, Goncalves-Primo A, Silva ID, Carvalho CR, et al. (2008) New approach reveals CD28 and IFNG gene interaction in the susceptibility to cervical cancer. Hum Mol Genet 17: 1838-1844. (Pubitemid 351791511)
48. Wang X, Meyers C, Guo M, Zheng ZM (2011) Upregulation of p18Ink4c expression by oncogenic HPV E6 via p53-miR-34a pathway. Int J Cancer 129: 1362-1372.
49. Li B, Hu Y, Ye F, Li Y, Lv W, et al. (2010) Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection. Int J Gynecol Cancer 20: 597-604.
50. Wang X, Wang HK, McCoy JP, Banerjee NS, Rader JS, et al. (2009) Oncogenic HPV infection interrupts the expression of tumor-suppressive miR-34a through viral oncoprotein E6. RNA 15: 637-647.
51. Borelli I, Barberis MA, Spina F, Casalis Cavalchini GC, Vivanet C, et al. (2013) A unique MSH2 exon 8 deletion accounts for a major portion of all mismatch repair genemutations in Lynch syndrome families of Sardinian origin. Eur J Hum Genet 21: 154-161.
52. Martin LM, Marples B, Davies AM, Atzberger A, Edwards C, et al. (2013) DNA mismatch repair protein MSH2 dictates cellular survival in response to low dose radiation in endometrial carcinoma cells. Cancer Lett 335: 19-25.
53. Nijhuis ER, Nijman HW, Oien KA, Bell A, ten Hoor KA, et al. (2007) Loss of MSH2 protein expression is a risk factor in early stage cervical cancer. J Clin Pathol 60: 824-830. (Pubitemid 47056915)
54. He M, Cheng Y, Li W, Liu Q, Liu J, et al. (2010) Vascular endothelial growth factor C promotes cervical cancer metastasis via up-regulation and activation of RhoA/ROCK-2/moesin cascade. BMC Cancer 10: 170.
55. Luke-Glaser S, Luke B, Grossi S, Constantinou A (2010) FANCM regulates DNA chain elongation and is stabilized by S-phase checkpoint signalling. EMBO J 29: 795-805.
56. Schwab RA, Blackford AN, Niedzwiedz W (2010) ATR activation and replication fork restart are defective in FANCM-deficient cells. EMBO J 29: 806-818.
57. Al-Mahrouki AA, Karshafian R, Giles A, Czarnota GJ (2012) Bioeffects of ultrasound-stimulated microbubbles on endothelial cells: gene expression changes associated with radiation enhancement in vitro. Ultrasound Med Biol 38: 1958-1969.
58. Choi YW, Bae SM, Kim YW, Lee HN, Park TC, et al. (2007) Gene expression profiles in squamous cell cervical carcinoma using array-based comparative genomic hybridization analysis. Int J Gynecol Cancer 17: 687-696. (Pubitemid 46743999)
59. Flohe L, Harris JR (2007) Introduction. History of the peroxiredoxins and topical perspectives. Subcell Biochem 44: 1-25.
60. Poynton RA, Hampton MB (2014) Peroxiredoxins as biomarkers of oxidative stress. Biochim Biophys Acta 1840: 906-912.
61. Giaginis C, Giagini A, Theocharis S (2009) Receptor-binding cancer antigen expressed on SiSo cells (RCAS1): a novel biomarker in the diagnosis and prognosis of human neoplasia. Histol Histopathol 24: 761-776.